Similar Survival with Two Ovarian Cancer Strategies, M. D. Anderson Cancer Center Study Published in The New England Journal of Medicine

MedPage Today -- Patients with bulky, advanced ovarian cancer survived just as long whether treated with neoadjuvant chemotherapy and surgery or with primary surgery followed by adjuvant chemotherapy, investigators in a multinational trial reported.